Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Hereditary Spherocytosis

Diseases of the Blood and Immune Mechanism

Hereditary spherocytosis is a congenital hemolytic disorder in which a genetic mutation affecting a structural membrane protein causes red blood cells to become sphere-shaped and rigid rather than their normal biconcave disk shape. This abnormal shape interferes with the cells' ability to flex during circulation and makes them more prone to rupture under osmotic or mechanical stress. Cells carrying the dysfunctional protein are degraded in the spleen, producing a shortage of red blood cells and resulting hemolytic anemia.

Facts
Classification
Body System
Lymphatic or Immune System 1
ICD-10 Chapter
III: Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism 1
Communicable or Non-communicable
Non-Communicable 2
Transmission Route
Non-Transmissible 3
First Described
1871 4
Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter III
Quote, List of chapters, Chapter III
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
View the Source
2. Wikipedia: Non-communicable disease
WikipediaNamed examples section
Quote, Named examples section
NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others.
View the Source
3. Wikipedia: Hereditary spherocytosis
WikipediaLead section, transmission-route statement
Quote, Lead section, transmission-route statement
Hereditary spherocytosis (HS) is a congenital hemolytic disorder wherein a genetic mutation coding for a structural membrane protein phenotype causes the red blood cells to be sphere-shaped and rigid (spherocytosis), rather than the normal biconcave disk shape.
View the Source
4. Hereditary spherocytosis (Wikipedia)
HS was first described in 1871, article introView the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.